Purchase Order 75N95019P00425
Award Date 7/26/19
Potential Completion Date 8/26/19
Potential Value $159K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Austria
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency of the U.S. government, to Biocrates Life Sciences AG, an Austrian company specializing in metabolomics assay kits, laboratory services, and targeted metabolite analysis. The contract, valued at $272,457.10, does not have a set-aside designation, indicating Biocrates competed for this award in an unrestricted manner. The contract involves the supply of Biocrates' products and...
- This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to Biocrates Life Sciences AG, an Austrian company that provides metabolomics assay kits and analytical services. The $525,058.55 contract is for Biocrates to perform metabolomic profiling of 3,021 human plasma samples from the Baltimore Longitudinal Study of Aging to examine the metabolic signatures underlying motor and cognitive decline related to...
- This firm-fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Eye Institute to Biocrates Life Sciences AG, an Austrian company doing business as Biocrates. The $20,500 contract is for Biocrates to provide ready-to-measure kits and laboratory services for quantitative, reproducible, and standardized mass spectrometry-based metabolomics analysis in support of biomedical, nutrition, and environmental health...
- The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a firm fixed price purchase order to Biocrates Life Sciences AG, doing business as Biocrates, for $422,572.24 to provide laboratory services for plasma samples processing. The contract has an August 9, 2021 completion date and was awarded on August 10, 2020. The contract is not set aside. Biocrates is a supplier of metabolomics assay kits and services that has received prior federal...
- The National Institute on Drug Abuse (NIDA) awarded a $106,704.75 firm-fixed-price purchase order to Biocrates Life Sciences AG, an Austrian company, for targeted metabolomics analyses of human brain tissue samples. This contract is not associated with a set-aside designation. Biocrates has extensive experience providing metabolomics assay kits, laboratory services, and targeted metabolite analysis capabilities to support biomedical research across federal agencies such as the NIH, USDA, and...
- This is a federal purchase order contract awarded by the National Institute on Aging, a civilian agency, to Biocrates Life Sciences AG, a for-profit Austrian company. The contract is for the delivery of Biocrates' MXP-QUANT 500 XL KITS, which are quantitative metabolomics assay kits. The contract has a firm-fixed-price of $24,265.60 and a period of performance ending on September 25, 2024. The contract does not have a set-aside designation, indicating it was competitively awarded. Biocrates...
- This is a federal purchase order contract awarded by the Food and Drug Administration (FDA) to Biocrates Life Sciences AG, an Austrian-based company specializing in metabolomics technologies and quantitative laboratory services. The contract is for the provision of Metabolomics Analysis Kits, with a ceiling value of $12,508.50 and a period of performance ending on April 16, 2016. The contract is a firm fixed-price agreement, with no set-aside designation. Biocrates Life Sciences AG is a...
- The National Institute on Drug Abuse awarded a $45,881.30 firm fixed-price purchase order to Biocrates Life Sciences AG, an Austrian-based metabolomics company, on September 4, 2020, for research supporting the study "Brain and Blood Bile Acid Concentrations in Cognitive Aging and Alzheimer's Disease." The contract was completed by September 29, 2021, and was not subject to any set-aside designation. Biocrates specializes in metabolomics technologies and quantitative laboratory...
- The U.S. government awarded a $28,038 firm fixed-price purchase order to Biocrates Life Sciences AG, an Austrian-based metabolomics technology company, on January 6, 2021. The contract calls for delivery of four Biocrates Quant 500 Kits, with a completion date of March 31, 2021. The award was issued through a special notice solicitation posted on December 22, 2020, with a response deadline of December 30, 2020. This competitive award includes no set-aside designation, reflecting Biocrates'...
- This is a $75,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), which is part of the Department of Health and Human Services (HHS), to Human Metabolome Technologies America, Inc., a self-certified small disadvantaged business based in Allston, Massachusetts. The contract is for metabolomics profiling services, which includes conducting metabolomic assays, lipidomic analyses, and targeted metabolomics on samples related to various areas of...